Neoadjuvant Treatment of Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Tamoxifen;   Drug: Goserelin;   Drug: Letrozole 2.5Mg Tab;   Drug: Epirubicin;   Drug: cyclophosphamide;   Drug: Docetaxel;   Drug: paclitaxel;   Drug: trastuzumab;   Drug: pertuzumab;   Drug: Capecitabine Sponsor:   National Institute of Oncology, Hungary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2021 Category: Research Source Type: clinical trials